The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I NANT study of lenalidomide with ch14.18 and isotretinoin (RA) in patients with refractory/recurrent neuroblastoma (RR-NB).
 
Araz Marachelian
Research Funding - Pfizer (Inst); United Therapeutics (Inst)
 
Judith Villablanca
No Relationships to Disclose
 
Angela Duvalyan
No Relationships to Disclose
 
Scarlett Czarnecki
Speakers' Bureau - United Therapeutics; United Therapeutics
 
Susan G. Groshen
Research Funding - Pfizer (Inst)
 
Denice Tsao-Wei
No Relationships to Disclose
 
Richard Sposto
Research Funding - Pfizer (Inst)
 
Jemily Malvar
No Relationships to Disclose
 
Jianping Sun
No Relationships to Disclose
 
Kelly C. Goldsmith
No Relationships to Disclose
 
Yael P. Mosse
Research Funding - Novartis (Inst)
 
Meaghan Granger
No Relationships to Disclose
 
Nita Seibel
No Relationships to Disclose
 
Jeffrey Moscow
No Relationships to Disclose
 
Katherine K. Matthay
No Relationships to Disclose
 
Michael Sheard
No Relationships to Disclose
 
Robert Seeger
No Relationships to Disclose